UNITED THERAPEUTICS Corp - Common Stock (UTHR)
CUSIP: 91307C102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,833,193
- Total 13F shares
- 45,751,455
- Share change
- +673,667
- Total reported value
- $14,568,456,882
- Put/Call ratio
- 111%
- Price per share
- $318.55
- Number of holders
- 557
- Value change
- +$331,436,428
- Number of buys
- 295
- Number of sells
- 244
Quarterly Holders Quick Answers
What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 91307C102:
Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
13%
|
5,567,530
|
$1,278,972,990 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
4,683,095
|
$1,075,800,583 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
8%
|
3,412,260
|
$783,864,368 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
6.7%
|
2,858,888
|
$656,743,751 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
5%
|
2,151,714
|
$494,292,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.5%
|
1,935,119
|
$444,535,537 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
2.4%
|
1,017,611
|
$233,765,513 | — | 31 Mar 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
2%
|
846,955
|
$194,562,503 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
828,271
|
$190,050,109 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.7%
|
719,311
|
$165,240,123 | — | 31 Mar 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.5%
|
635,347
|
$145,949,942 | — | 31 Mar 2024 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
1.3%
|
573,075
|
$131,646,728 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
563,286
|
$129,398,170 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
536,208
|
$123,177,950 | — | 31 Mar 2024 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
1.2%
|
529,519
|
$121,641,000 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.1%
|
473,285
|
$108,723,030 | — | 31 Mar 2024 | |
| Pacer Advisors, Inc. |
13F
|
Company |
1.1%
|
469,594
|
$107,875,134 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
464,874
|
$106,883,808 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
464,537
|
$106,713,440 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
458,333
|
$105,288,269 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
1%
|
442,672
|
$101,690,613 | — | 31 Mar 2024 | |
| Swedbank AB |
13F
|
Company |
0.99%
|
423,630
|
$97,316,284 | — | 31 Mar 2024 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.98%
|
420,058
|
$96,495,725 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.93%
|
398,437
|
$91,528,948 | — | 31 Mar 2024 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.7%
|
300,920
|
$72,422,416 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.73%
|
314,111
|
$72,157,579 | — | 31 Mar 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.69%
|
295,756
|
$67,941,155 | — | 31 Mar 2024 | |
| ASSETMARK, INC |
13F
|
Company |
0.63%
|
270,162
|
$62,061,615 | — | 31 Mar 2024 | |
| Palo Alto Investors LP |
13F
|
Company |
0.63%
|
267,759
|
$61,509,597 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.61%
|
259,749
|
$59,669,540 | — | 31 Mar 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.6%
|
256,736
|
$58,977,394 | — | 31 Mar 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.59%
|
252,024
|
$57,895,000 | — | 31 Mar 2024 | |
| Eversept Partners, LP |
13F
|
Company |
0.59%
|
251,135
|
$57,690,732 | — | 31 Mar 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.51%
|
217,000
|
$49,849,240 | — | 31 Mar 2024 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.51%
|
216,354
|
$49,700,841 | — | 31 Mar 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.5%
|
216,124
|
$49,648,005 | — | 31 Mar 2024 | |
| Epoch Investment Partners, Inc. |
13F
|
Company |
0.5%
|
213,498
|
$49,044,760 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.47%
|
203,029
|
$46,639,822 | — | 31 Mar 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.43%
|
184,934
|
$42,483,233 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.43%
|
184,657
|
$42,419,406 | — | 31 Mar 2024 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.43%
|
182,991
|
$42,036,693 | — | 31 Mar 2024 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.42%
|
180,800
|
$41,533,376 | — | 31 Mar 2024 | |
| Robeco Institutional Asset Management B.V. |
13F
|
Company |
0.42%
|
180,066
|
$41,364,764 | — | 31 Mar 2024 | |
| Eagle Health Investments LP |
13F
|
Company |
0.42%
|
179,499
|
$41,234,510 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.41%
|
177,501
|
$40,775,530 | — | 31 Mar 2024 | |
| WEDGE CAPITAL MANAGEMENT L L P/NC |
13F
|
Company |
0.4%
|
170,549
|
$39,178,516 | — | 31 Mar 2024 | |
| Amundi |
13F
|
Individual |
0.39%
|
165,030
|
$39,100,558 | — | 31 Mar 2024 | |
| COMERICA BANK |
13F
|
Company |
0.39%
|
165,911
|
$38,113,042 | — | 31 Mar 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.38%
|
164,622
|
$37,816,966 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.38%
|
162,700
|
$37,375,444 | — | 31 Mar 2024 |
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2024
As of 30 Jun 2024,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
557 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,751,455 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, CITIGROUP INC, GEODE CAPITAL MANAGEMENT, LLC, LSV ASSET MANAGEMENT, and MORGAN STANLEY.
This page lists
558
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
518
Q2 2024 holders
557
Holder diff
39
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.